From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 2, p. 8
- Publication type:
- Article
Works matching IS 10685308 AND DT 2012 AND VI 23 AND IP 2
Results: 10
1
2
Delirium following addition of adjunctive quetiapine/valproate in BP.
- Published in:
- 2012
- Publication type:
- Case Study
3
Mortality in antipsychotic-induced neuroleptic malignant syndrome.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 2, p. 7
- Publication type:
- Article
4
Increased risks of suicidal behavior and depression with varenicline in smoking cessation.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 2, p. 7
- Publication type:
- Article
5
Commentary on Cooper et al.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
6
Why psychiatrists should treat smoking.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 2, p. 4
- By:
- Publication type:
- Article
7
Maintenance treatment of bipolar I disorder.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 2, p. 3
- Publication type:
- Article
8
Zolpidem safe for long-term use in physically and mentally healthy patients.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 2, p. 1, doi. 10.1177/0269881111424455
- Publication type:
- Article
9
No increased risk of serious cardiovascular events with ADHD drugs in children or adults.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 2, p. 1
- Publication type:
- Article
10
Mirtazapine reduces methamphetamine use and sexual risk behavior in men who have sex with men.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 2, p. 2
- Publication type:
- Article